This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24/7 Access
Digital & In-Person

Arthur Levin, PhD
Executive Vice President, R&D at Avidity Biosciences LLC


Artificial Intelligence (AI) can drive cars, beat humans at their own games and transcribe speech. Biology and medicine present much greater challenges, but the recent exponential growth in biomedical data has made AI assisted drug development a reality. Brendan Frey, a pioneer in this field, will discuss how Deep Genomics is using AI for target discovery and drug development, and give his perspective on the opportunities and challenges that lie ahead,
such as guaranteeing prediction accuracy and establishing trust with clinicians and regulators.